Gland Pharma
Quarterly Results Analysis [Mar2022]

Gland Pharma is part of below Screeners ↓
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for Gland Pharma
Please provide your vote to see the results

Gland Pharma Quarterly Results

Consolidated Mar2022
Audited
Dec2021
UnAudited
Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
UnAudited
Revenues ₹1,103 Cr ₹1,063 Cr ₹1,080 Cr ₹1,154 Cr ₹888 Cr ₹859 Cr ₹832 Cr ₹884 Cr
Expenses ₹755 Cr ₹714 Cr ₹704 Cr ₹718 Cr ₹560 Cr ₹595 Cr ₹534 Cr ₹472 Cr
Operating Income ₹348 Cr ₹349 Cr ₹377 Cr ₹436 Cr ₹328 Cr ₹264 Cr ₹298 Cr ₹413 Cr
Other Income ₹65 Cr ₹46 Cr ₹51 Cr ₹62 Cr ₹47 Cr ₹35 Cr ₹20 Cr ₹32 Cr
Interest ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr
Depreciation ₹31 Cr ₹28 Cr ₹26 Cr ₹25 Cr ₹25 Cr ₹25 Cr ₹25 Cr ₹24 Cr
Profit Before Tax ₹380 Cr ₹366 Cr ₹401 Cr ₹472 Cr ₹349 Cr ₹273 Cr ₹293 Cr ₹420 Cr
Profit After Tax ₹286 Cr ₹273 Cr ₹302 Cr ₹351 Cr ₹260 Cr ₹204 Cr ₹219 Cr ₹314 Cr
EPS ₹17.40 ₹16.62 ₹18.39 ₹21.39 ₹15.92 ₹12.50 ₹14.12 ₹20.24
Industry Peers & Returns1W1M1Y
Gland Pharma -1.3% -6.3% 1%
SUN PHARMACEUTICAL INDUSTRIES 3.4% -0.8% 28%
DIVIS LABORATORIES 2.1% -3.3% 4.4%
DR REDDYS LABORATORIES 9.2% -1.1% -24.4%
CIPLA 4.9% -3.3% 6.1%
PIRAMAL ENTERPRISES 2.3% -13.7% 12%
CADILA HEALTHCARE 3.5% -0.9% -44%
TORRENT PHARMACEUTICALS 3.1% -6.9% -4.9%
ALKEM LABORATORIES 3.4% -11.9% -1.1%

Gland Pharma Quarterly Revenues

Revenues
Q-o-Q

3.73 %

Y-o-Y

24.25 %

Quarters Revenues % Change
Mar2022 ₹1,103 Cr
3.73
Dec2021 ₹1,063 Cr
-1.59
Sep2021 ₹1,080 Cr
-6.36
Jun2021 ₹1,154 Cr
29.98
Mar2021 ₹888 Cr
3.30
Dec2020 ₹859 Cr
3.36
Sep2020 ₹832 Cr
-5.96
Jun2020 ₹884 Cr -

Gland Pharma Quarterly Operating Profit

Operating Profit
Q-o-Q

-0.16 %

Y-o-Y

6.31 %

Quarters Operating Profit % Change
Mar2022 ₹348 Cr
-0.16
Dec2021 ₹349 Cr
-7.35
Sep2021 ₹377 Cr
-13.68
Jun2021 ₹436 Cr
33.15
Mar2021 ₹328 Cr
24.01
Dec2020 ₹264 Cr
-11.24
Sep2020 ₹298 Cr
-27.85
Jun2020 ₹413 Cr -
Operating Margins
Q-o-Q

-3.75 %

Y-o-Y

-14.44 %

Quarters Operating Margin% % Change
Mar2022 31.58%
-3.75
Dec2021 32.81%
-5.88
Sep2021 34.86%
-7.80
Jun2021 37.81%
2.44
Mar2021 36.91%
20.03
Dec2020 30.75%
-14.11
Sep2020 35.8%
-23.29
Jun2020 46.67% -

Gland Pharma Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

4.71 %

Y-o-Y

9.79 %

Quarters Profit After Tax % Change
Mar2022 ₹286 Cr
4.71
Dec2021 ₹273 Cr
-9.62
Sep2021 ₹302 Cr
-13.85
Jun2021 ₹351 Cr
34.65
Mar2021 ₹260 Cr
27.58
Dec2020 ₹204 Cr
-6.74
Sep2020 ₹219 Cr
-30.21
Jun2020 ₹314 Cr -
PAT Margins
Q-o-Q

0.93 %

Y-o-Y

-11.63 %

Quarters PAT Margin(%) % Change
Mar2022 25.92 %
0.93
Dec2021 25.68 %
-8.15
Sep2021 27.96 %
-8.00
Jun2021 30.39 %
3.61
Mar2021 29.33 %
23.49
Dec2020 23.75 %
-9.76
Sep2020 26.32 %
-25.80
Jun2020 35.47 % -

Gland Pharma Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

4.69 %

Y-o-Y

9.30 %

Quarters EPS % Change
Mar2022 ₹17.4
4.69
Dec2021 ₹16.62
-9.62
Sep2021 ₹18.39
-14.03
Jun2021 ₹21.39
34.36
Mar2021 ₹15.92
27.36
Dec2020 ₹12.5
-11.47
Sep2020 ₹14.12
-30.24
Jun2020 ₹20.24 -

Gland Pharma related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 3.7% -8.4% 12.6%
S&P BSE ALLCAP 3.2% -5.8% 10.3%
S&P BSE MID CAP 3.2% -8% 8%
S&P BSE 500 3.2% -5.6% 9.7%
S&P BSE LARGE MIDCAP 3.1% -5.2% 9.2%
S&P BSE 250 LARGEMIDCAP 3.1% -5.3% 9.5%
S&P BSE 200 3.1% -5.2% 9.3%
S&P BSE 100 LARGECAP TMC 3% -4.9% 9.1%
S&P BSE HEALTHCARE 2.8% -6.4% -4.8%
NSE Indices1W1M1Y
NIFTY PHARMA 3.5% -3.4% -5.7%
NIFTY500 MULTICAP 50:25:25 3.4% -6.8% 11%
NIFTY MNC 3.3% -2.6% 8%
NIFTY 500 3.1% -5.7% 9.7%
NIFTY 100 3.1% -4.9% 8.9%
NIFTY 200 3% -5.3% 9.3%
NIFTY LARGE MIDCAP 250 3% -6% 10.5%
NIFTY 100 EQUAL WEIGHT 2.9% -7% 6.9%
NIFTY NEXT 50 2.8% -9.3% 6.4%
NIFTY 100 ALPHA 30 0.2% -15.1% 10.3%

You may also like the below Video Courses



SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z